Market Place
Sourcing Support
Celmatix & Aché Announce Collaboration to Investigate a Novel Melatonin Receptor
08 Aug 2023 //
BUSINESSWIRE
Celmatix Announces Breakthrough in Novel Oral Fertility Drug Program
27 Jun 2023 //
BUSINESSWIRE
Celmatix Appoints Drug Development Expert Dr. Susan Herbert
16 May 2023 //
BUSINESSWIRE
Celmatix Launches Novel PCOS Drug Program
13 Apr 2023 //
BUSINESSWIRE
Celmatix Achieves Milestone for PCOS Drug Program
04 Jan 2023 //
BUSINESSWIRE
Celmatix Appoints Seasoned Litigator Craig Bolton as General Counsel
20 Jul 2022 //
BUSINESSWIRE
Celmatix Appoints Dr. Bart Fauser to Chairmanship of Scientific Advisory Board
05 Jul 2022 //
BUSINESSWIRE
CelmatixAchieves Key Preclinical Milestones in Premature Menopause PDD
16 May 2022 //
BUSINESSWIRE
Evotec partner Celmatix achieves milestone for PCOS drug programme
18 Jan 2022 //
PRESS RELEASE
Celmatix Achieves Milestone for PCOS Drug Program
18 Jan 2022 //
BUSINESSWIRE
Celmatix Appoints Merck R&D Veteran Stephen Palmer to Chief Scientific Officer
26 May 2021 //
BUSINESSWIRE
Celmatix Announces New Advisory Board
23 Sep 2020 //
BUSINESSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.